Inactive Instrument
Aradigm Corporation Share Price Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 48.85L 41.87L 39.17L 35.81L 67.57L 47Cr 68.29L 4.63Cr 1.8Cr 23Cr 1.83Cr 1.79Cr 78Cr | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.28Cr 1.1Cr 1.03Cr 93.81L 1.77Cr 122.55Cr 1.79Cr 12Cr 4.72Cr 62Cr 4.81Cr 4.7Cr 203.6Cr | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +36.88% | +25.50% | - | - | 7L | ||
| -0.74% | +3.78% | +3.74% | +23.10% | 5.16TCr | ||
| +1.01% | -0.20% | +471.68% | +564.93% | 4.49TCr | ||
| +0.16% | +7.88% | +36.14% | +20.76% | 4.28TCr | ||
| -0.66% | +2.61% | +18.59% | +87.04% | 4.26TCr | ||
| +0.88% | -3.48% | +17.20% | +57.20% | 3.18TCr | ||
| -0.12% | +3.84% | +33.73% | +145.25% | 1.73TCr | ||
| -0.53% | +1.84% | - | - | 1.66TCr | ||
| +0.58% | +4.66% | +7.17% | +30.87% | 1.48TCr | ||
| +1.15% | +4.17% | +84.49% | +50.33% | 1.41TCr | ||
| Average | +3.86% | +4.62% | +84.09% | +122.43% | 3.07TCr | |
| Weighted average by Cap. | +0.10% | +4.83% | +100.58% | +141.04% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 2L 2L 2L 1L 3L 1.87Cr 3L 18.5L 7L 93.76L 7L 7L 3.1Cr | 1.45Cr 1.24Cr 1.16Cr 1.06Cr 2Cr 138.51Cr 2.02Cr 14Cr 5.34Cr 70Cr 5.43Cr 5.31Cr 230.11Cr |
| Net income | -3.29Cr -2.82Cr -2.64Cr -2.41Cr -4.56Cr -315.39Cr -4.6Cr -31Cr -12Cr -158.37Cr -12Cr -12Cr -523.99Cr | -1.07Cr -91.74L -85.83L -78.47L -1.48Cr -102.5Cr -1.5Cr -10Cr -3.95Cr -51Cr -4.02Cr -3.93Cr -170.3Cr |
| Net Debt | -93.72L -80.32L -75.14L -68.69L -1.3Cr -90Cr -1.31Cr -8.89Cr -3.46Cr -45Cr -3.52Cr -3.44Cr -149.09Cr | 79.13L 67.81L 63.44L 58L 1.09Cr 76Cr 1.11Cr 7.51Cr 2.92Cr 38Cr 2.97Cr 2.91Cr 125.88Cr |
Employees
-
















